Skip to content

QURE

uniQure N.V.

NASDAQ · Healthcare · Biotechnology · NL

$44.50
−0.80%
Ask drillr
0
Insider buys (3m)
35
Insider sells (3m)
-$16.7M
Net value (3m)
+67.9%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 7, 2026Kapusta Matthew C · director, officer: CEO, Managing DirectorSale4,282$45
Jul 7, 2026Kapusta Matthew C · director, officer: CEO, Managing DirectorSale7,600$46
Jul 7, 2026Kapusta Matthew C · director, officer: CEO, Managing DirectorM-Exempt21,082$19
Jul 7, 2026Kapusta Matthew C · director, officer: CEO, Managing DirectorSale9,200$44
Jul 2, 2026Kaye Jack · directorM-Exempt4,107$37
Jul 2, 2026Abi-Saab Walid · officer: Chief Medical OfficerSale10,000$46
Jul 2, 2026Abi-Saab Walid · officer: Chief Medical OfficerM-Exempt10,000$5.59
Jul 2, 2026Abi-Saab Walid · officer: Chief Medical OfficerSale20,000$46
Jul 2, 2026Kaye Jack · directorSale4,107$46
Jul 2, 2026Kaye Jack · directorM-Exempt17,060$20
Jul 2, 2026Kaye Jack · directorSale17,060$46
Jun 30, 2026Abi-Saab Walid · officer: Chief Medical OfficerSale1,434$47
Jun 26, 2026Kapusta Matthew C · director, officer: CEO, Managing DirectorSale6,696$50
Jun 26, 2026Kapusta Matthew C · director, officer: CEO, Managing DirectorM-Exempt4,128$32
Jun 26, 2026Kapusta Matthew C · director, officer: CEO, Managing DirectorSale28,716$50
Jun 26, 2026Kapusta Matthew C · director, officer: CEO, Managing DirectorM-Exempt28,716$32
Jun 22, 2026Kapusta Matthew C · director, officer: CEO, Managing DirectorSale4,656$50
Jun 22, 2026Kapusta Matthew C · director, officer: CEO, Managing DirectorSale11,585$49
Jun 22, 2026Balachandran Madhavan · directorSale4,700$44
Jun 22, 2026Kapusta Matthew C · director, officer: CEO, Managing DirectorM-Exempt62,581$19
Jun 22, 2026Kapusta Matthew C · director, officer: CEO, Managing DirectorM-Exempt4,656$32
Jun 22, 2026Kapusta Matthew C · director, officer: CEO, Managing DirectorSale37,015$50
Jun 22, 2026Kaye Jack · directorSale5,295$43
Jun 22, 2026Kaye Jack · directorM-Exempt5,295$32
Jun 22, 2026Kapusta Matthew C · director, officer: CEO, Managing DirectorSale23,977$43
Jun 22, 2026Balachandran Madhavan · directorM-Exempt6,390$19
Jun 22, 2026Kapusta Matthew C · director, officer: CEO, Managing DirectorSale33,334$45
Jun 22, 2026Kapusta Matthew C · director, officer: CEO, Managing DirectorSale32,581$45
Jun 22, 2026Balachandran Madhavan · directorSale1,690$43
Jun 22, 2026Balachandran Madhavan · directorM-Exempt5,295$32
Institutional positioning

13F filings over the trailing two quarters

New 136Increased 169Reduced 131Sold out 52
FilerActionSharesFiled
Avoro Capital Advisors LLCIncreased6,727,777Aug 14, 2026
AVORO CAPITAL ADVISORS LLCIncreased6,150,000Mar 16, 2026
AVORO CAPITAL ADVISORS LLCReduced5,959,595May 15, 2026
ABRDN PLCIncreased5,306,386Apr 29, 2026
JPMORGAN CHASE & COIncreased4,867,755Aug 12, 2026
RTW INVESTMENTS, LPIncreased3,941,572Aug 14, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPReduced3,644,200May 15, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPReduced3,494,697Aug 14, 2026
STATE STREET CORPIncreased2,903,825Aug 7, 2026
Aberdeen Group plcReduced2,848,117Jul 31, 2026
JPMORGAN CHASE & COReduced2,837,466May 13, 2026
NANTAHALA CAPITAL MANAGEMENT, LLCIncreased2,837,078May 15, 2026
CITIGROUP INCIncreased2,811,485May 11, 2026
TWO SIGMA INVESTMENTS, LPIncreased2,675,871May 15, 2026
RTW INVESTMENTS, LPReduced2,586,356May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 7, 2026